nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS1—malignant glioma	0.496	0.636	CbGaD
Aminosalicylic Acid—PTGS2—malignant glioma	0.284	0.364	CbGaD
Aminosalicylic Acid—MPO—endothelium—malignant glioma	0.00203	0.124	CbGeAlD
Aminosalicylic Acid—MPO—blood vessel—malignant glioma	0.00187	0.115	CbGeAlD
Aminosalicylic Acid—Mesalazine—PPARG—malignant glioma	0.00113	0.224	CrCbGaD
Aminosalicylic Acid—Diflunisal—PTGS1—malignant glioma	0.00106	0.211	CrCbGaD
Aminosalicylic Acid—CHUK—cerebellum—malignant glioma	0.00106	0.0648	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—malignant glioma	0.000963	0.0589	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—malignant glioma	0.000921	0.0563	CbGeAlD
Aminosalicylic Acid—PTGS1—blood vessel—malignant glioma	0.000888	0.0544	CbGeAlD
Aminosalicylic Acid—CHUK—brain—malignant glioma	0.00086	0.0526	CbGeAlD
Aminosalicylic Acid—PTGS2—blood vessel—malignant glioma	0.000849	0.052	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS1—malignant glioma	0.000834	0.165	CrCbGaD
Aminosalicylic Acid—Encephalopathy—Carmustine—malignant glioma	0.000805	0.0769	CcSEcCtD
Aminosalicylic Acid—MPO—spinal cord—malignant glioma	0.000636	0.0389	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—malignant glioma	0.00061	0.0373	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—malignant glioma	0.000607	0.121	CrCbGaD
Aminosalicylic Acid—ALOX5—cerebellum—malignant glioma	0.000596	0.0365	CbGeAlD
Aminosalicylic Acid—Salicylic acid—PTGS1—malignant glioma	0.000591	0.117	CrCbGaD
Aminosalicylic Acid—MPO—central nervous system—malignant glioma	0.000516	0.0316	CbGeAlD
Aminosalicylic Acid—PTGS2—embryo—malignant glioma	0.000506	0.031	CbGeAlD
Aminosalicylic Acid—ALOX5—brain—malignant glioma	0.000484	0.0296	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS2—malignant glioma	0.000477	0.0946	CrCbGaD
Aminosalicylic Acid—PTGS1—telencephalon—malignant glioma	0.000431	0.0264	CbGeAlD
Aminosalicylic Acid—PTGS2—telencephalon—malignant glioma	0.000412	0.0252	CbGeAlD
Aminosalicylic Acid—MPO—brain—malignant glioma	0.00041	0.0251	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Temozolomide—malignant glioma	0.000405	0.0387	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000384	0.0367	CcSEcCtD
Aminosalicylic Acid—Purpura—Temozolomide—malignant glioma	0.000376	0.0359	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000375	0.0358	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—malignant glioma	0.000338	0.0671	CrCbGaD
Aminosalicylic Acid—PTGS2—medulla oblongata—malignant glioma	0.000324	0.0198	CbGeAlD
Aminosalicylic Acid—Abdominal distension—Temozolomide—malignant glioma	0.000315	0.0301	CcSEcCtD
Aminosalicylic Acid—PTGS1—spinal cord—malignant glioma	0.000302	0.0185	CbGeAlD
Aminosalicylic Acid—PTGS2—midbrain—malignant glioma	0.000296	0.0181	CbGeAlD
Aminosalicylic Acid—PTGS2—spinal cord—malignant glioma	0.000289	0.0177	CbGeAlD
Aminosalicylic Acid—Weight decreased—Temozolomide—malignant glioma	0.000283	0.0271	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Carmustine—malignant glioma	0.000283	0.0271	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Temozolomide—malignant glioma	0.000274	0.0262	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Temozolomide—malignant glioma	0.000251	0.024	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Temozolomide—malignant glioma	0.000248	0.0237	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Temozolomide—malignant glioma	0.000246	0.0235	CcSEcCtD
Aminosalicylic Acid—PTGS1—central nervous system—malignant glioma	0.000245	0.015	CbGeAlD
Aminosalicylic Acid—PTGS2—central nervous system—malignant glioma	0.000234	0.0143	CbGeAlD
Aminosalicylic Acid—PTGS2—cerebellum—malignant glioma	0.000229	0.014	CbGeAlD
Aminosalicylic Acid—Malnutrition—Carmustine—malignant glioma	0.000226	0.0216	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Temozolomide—malignant glioma	0.000218	0.0209	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Temozolomide—malignant glioma	0.000214	0.0204	CcSEcCtD
Aminosalicylic Acid—Anaemia—Carmustine—malignant glioma	0.000209	0.0199	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Carmustine—malignant glioma	0.000202	0.0193	CcSEcCtD
Aminosalicylic Acid—Anaemia—Temozolomide—malignant glioma	0.000202	0.0193	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Temozolomide—malignant glioma	0.000195	0.0187	CcSEcCtD
Aminosalicylic Acid—PTGS1—brain—malignant glioma	0.000194	0.0119	CbGeAlD
Aminosalicylic Acid—PTGS2—brain—malignant glioma	0.000186	0.0114	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000184	0.0176	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Carmustine—malignant glioma	0.00018	0.0172	CcSEcCtD
Aminosalicylic Acid—Anorexia—Carmustine—malignant glioma	0.000176	0.0168	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Temozolomide—malignant glioma	0.000175	0.0167	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Temozolomide—malignant glioma	0.000174	0.0167	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Temozolomide—malignant glioma	0.000173	0.0165	CcSEcCtD
Aminosalicylic Acid—Anorexia—Temozolomide—malignant glioma	0.00017	0.0162	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Carmustine—malignant glioma	0.00016	0.0153	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Carmustine—malignant glioma	0.000159	0.0152	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Temozolomide—malignant glioma	0.000155	0.0148	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000154	0.0147	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Carmustine—malignant glioma	0.000151	0.0144	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Carmustine—malignant glioma	0.000146	0.0139	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carmustine—malignant glioma	0.000146	0.0139	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Temozolomide—malignant glioma	0.000146	0.0139	CcSEcCtD
Aminosalicylic Acid—Urticaria—Temozolomide—malignant glioma	0.000141	0.0135	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Temozolomide—malignant glioma	0.000141	0.0135	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Temozolomide—malignant glioma	0.000141	0.0135	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Carmustine—malignant glioma	0.000136	0.013	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Temozolomide—malignant glioma	0.000131	0.0125	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Carmustine—malignant glioma	0.000126	0.012	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carmustine—malignant glioma	0.000122	0.0116	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Temozolomide—malignant glioma	0.000122	0.0116	CcSEcCtD
Aminosalicylic Acid—Dizziness—Temozolomide—malignant glioma	0.000118	0.0113	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carmustine—malignant glioma	0.000117	0.0112	CcSEcCtD
Aminosalicylic Acid—Rash—Carmustine—malignant glioma	0.000116	0.0111	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carmustine—malignant glioma	0.000116	0.0111	CcSEcCtD
Aminosalicylic Acid—Headache—Carmustine—malignant glioma	0.000115	0.011	CcSEcCtD
Aminosalicylic Acid—Vomiting—Temozolomide—malignant glioma	0.000113	0.0108	CcSEcCtD
Aminosalicylic Acid—Rash—Temozolomide—malignant glioma	0.000112	0.0107	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Temozolomide—malignant glioma	0.000112	0.0107	CcSEcCtD
Aminosalicylic Acid—Headache—Temozolomide—malignant glioma	0.000112	0.0107	CcSEcCtD
Aminosalicylic Acid—Nausea—Carmustine—malignant glioma	0.000109	0.0105	CcSEcCtD
Aminosalicylic Acid—Nausea—Temozolomide—malignant glioma	0.000106	0.0101	CcSEcCtD
Aminosalicylic Acid—PTGS2—Disease—IDH1—malignant glioma	3.56e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAG2—malignant glioma	3.54e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—malignant glioma	3.53e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.48e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—IDH2—malignant glioma	3.47e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAV1—malignant glioma	3.45e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CD—malignant glioma	3.42e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF2—malignant glioma	3.41e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PIK3CA—malignant glioma	3.38e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HEY1—malignant glioma	3.38e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.36e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PIK3CA—malignant glioma	3.32e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.29e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIST1H3B—malignant glioma	3.28e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF2—malignant glioma	3.28e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.27e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2B6—malignant glioma	3.26e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTK2—malignant glioma	3.25e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2—malignant glioma	3.24e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.2e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MDM2—malignant glioma	3.19e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RAF1—malignant glioma	3.18e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB2—malignant glioma	3.15e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CG—malignant glioma	3.14e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.13e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CB—malignant glioma	3.11e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN2B—malignant glioma	3.09e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—MDM2—malignant glioma	3.07e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—malignant glioma	3.06e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.06e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RAF1—malignant glioma	3.05e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDGFRA—malignant glioma	3.04e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—malignant glioma	3.03e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—malignant glioma	3.02e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB2—malignant glioma	3.02e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—H3F3A—malignant glioma	2.99e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAG2—malignant glioma	2.99e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CB—malignant glioma	2.98e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—IDH1—malignant glioma	2.98e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.98e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCR3—malignant glioma	2.97e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.96e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HES1—malignant glioma	2.95e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.95e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NCOR1—malignant glioma	2.94e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SPHK1—malignant glioma	2.89e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—YWHAE—malignant glioma	2.88e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK2—malignant glioma	2.88e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTT1—malignant glioma	2.88e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FLT1—malignant glioma	2.87e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DUSP6—malignant glioma	2.86e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2C18—malignant glioma	2.83e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAG1—malignant glioma	2.82e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH3—malignant glioma	2.81e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PDGFRA—malignant glioma	2.81e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—malignant glioma	2.8e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FBXW7—malignant glioma	2.77e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CD—malignant glioma	2.76e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDGFB—malignant glioma	2.73e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR1—malignant glioma	2.72e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.72e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BDKRB2—malignant glioma	2.71e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—malignant glioma	2.71e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.69e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—malignant glioma	2.68e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.67e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.63e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TERT—malignant glioma	2.59e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—malignant glioma	2.59e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—malignant glioma	2.58e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—H3F3A—malignant glioma	2.53e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PDGFB—malignant glioma	2.52e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH2—malignant glioma	2.52e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR1—malignant glioma	2.51e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—malignant glioma	2.51e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC5A5—malignant glioma	2.48e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIF1A—malignant glioma	2.47e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KNG1—malignant glioma	2.47e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BAD—malignant glioma	2.44e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.43e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CB—malignant glioma	2.41e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CAV1—malignant glioma	2.39e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAG1—malignant glioma	2.39e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—malignant glioma	2.38e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD80—malignant glioma	2.36e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK1—malignant glioma	2.35e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.34e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.34e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FBXW7—malignant glioma	2.34e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGF—malignant glioma	2.33e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.32e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPN11—malignant glioma	2.32e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTT1—malignant glioma	2.29e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BAD—malignant glioma	2.25e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—malignant glioma	2.23e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.22e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP3—malignant glioma	2.19e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD80—malignant glioma	2.18e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—malignant glioma	2.18e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APC—malignant glioma	2.18e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—malignant glioma	2.17e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT2—malignant glioma	2.16e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGF—malignant glioma	2.15e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTGS1—malignant glioma	2.14e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTPN11—malignant glioma	2.14e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.13e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTK2—malignant glioma	2.1e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—malignant glioma	2.09e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—malignant glioma	2.08e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CD—malignant glioma	2.08e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—malignant glioma	2.07e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—malignant glioma	2.06e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCOR1—malignant glioma	2.06e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—malignant glioma	2.05e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.02e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—malignant glioma	2e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT2—malignant glioma	1.99e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—malignant glioma	1.99e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF2—malignant glioma	1.99e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—malignant glioma	1.98e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRA—malignant glioma	1.97e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC5A5—malignant glioma	1.97e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAT—malignant glioma	1.94e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CD—malignant glioma	1.92e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—malignant glioma	1.91e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—malignant glioma	1.89e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—malignant glioma	1.89e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—malignant glioma	1.87e-05	9.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.86e-05	9.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MDM2—malignant glioma	1.86e-05	9.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAF1—malignant glioma	1.85e-05	9.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF2—malignant glioma	1.83e-05	9.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NCOR1—malignant glioma	1.83e-05	9.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—malignant glioma	1.83e-05	9.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—malignant glioma	1.83e-05	9.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—malignant glioma	1.82e-05	9.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—malignant glioma	1.81e-05	9.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CB—malignant glioma	1.81e-05	9.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFB—malignant glioma	1.77e-05	9.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR1—malignant glioma	1.76e-05	9.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—malignant glioma	1.75e-05	9.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCOR1—malignant glioma	1.74e-05	9.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—malignant glioma	1.73e-05	9.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MDM2—malignant glioma	1.72e-05	9.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RAF1—malignant glioma	1.71e-05	9.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—malignant glioma	1.69e-05	8.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CAV1—malignant glioma	1.68e-05	8.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CB—malignant glioma	1.67e-05	8.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—malignant glioma	1.67e-05	8.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRA—malignant glioma	1.67e-05	8.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—malignant glioma	1.66e-05	8.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—malignant glioma	1.66e-05	8.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—malignant glioma	1.65e-05	8.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.61e-05	8.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—F2—malignant glioma	1.59e-05	8.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FN1—malignant glioma	1.59e-05	8.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—malignant glioma	1.58e-05	8.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BAD—malignant glioma	1.58e-05	8.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—malignant glioma	1.56e-05	8.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—malignant glioma	1.56e-05	8.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—malignant glioma	1.55e-05	8.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAT—malignant glioma	1.54e-05	8.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—malignant glioma	1.53e-05	8.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—malignant glioma	1.53e-05	8.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD80—malignant glioma	1.53e-05	8.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—malignant glioma	1.53e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—malignant glioma	1.53e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGF—malignant glioma	1.51e-05	8.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTPN11—malignant glioma	1.5e-05	7.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFB—malignant glioma	1.5e-05	7.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAV1—malignant glioma	1.5e-05	7.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR1—malignant glioma	1.49e-05	7.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—malignant glioma	1.49e-05	7.89e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—malignant glioma	1.47e-05	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—malignant glioma	1.47e-05	7.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NCOR1—malignant glioma	1.46e-05	7.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—malignant glioma	1.44e-05	7.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—malignant glioma	1.43e-05	7.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.43e-05	7.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CAV1—malignant glioma	1.42e-05	7.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—malignant glioma	1.4e-05	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT2—malignant glioma	1.4e-05	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—malignant glioma	1.36e-05	7.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CD—malignant glioma	1.34e-05	7.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BAD—malignant glioma	1.33e-05	7.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—malignant glioma	1.32e-05	7.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—malignant glioma	1.31e-05	6.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD80—malignant glioma	1.29e-05	6.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—malignant glioma	1.29e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—malignant glioma	1.29e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF2—malignant glioma	1.28e-05	6.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGF—malignant glioma	1.28e-05	6.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—malignant glioma	1.27e-05	6.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTPN11—malignant glioma	1.27e-05	6.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—malignant glioma	1.21e-05	6.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MDM2—malignant glioma	1.2e-05	6.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—malignant glioma	1.2e-05	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—malignant glioma	1.2e-05	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—malignant glioma	1.2e-05	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAF1—malignant glioma	1.2e-05	6.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CD—malignant glioma	1.2e-05	6.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAV1—malignant glioma	1.19e-05	6.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—malignant glioma	1.19e-05	6.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT2—malignant glioma	1.18e-05	6.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—malignant glioma	1.17e-05	6.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CB—malignant glioma	1.17e-05	6.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CD—malignant glioma	1.13e-05	6.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.13e-05	6.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—malignant glioma	1.12e-05	5.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—malignant glioma	1.11e-05	5.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—malignant glioma	1.1e-05	5.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF2—malignant glioma	1.09e-05	5.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—malignant glioma	1.08e-05	5.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—malignant glioma	1.08e-05	5.71e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—malignant glioma	1.07e-05	5.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CB—malignant glioma	1.04e-05	5.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—malignant glioma	1.04e-05	5.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—malignant glioma	1.03e-05	5.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—malignant glioma	1.02e-05	5.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MDM2—malignant glioma	1.02e-05	5.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—malignant glioma	1.02e-05	5.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RAF1—malignant glioma	1.01e-05	5.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—malignant glioma	1.01e-05	5.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—malignant glioma	1e-05	5.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CB—malignant glioma	9.89e-06	5.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CD—malignant glioma	9.51e-06	5.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—malignant glioma	9.13e-06	4.85e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—malignant glioma	9.04e-06	4.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—malignant glioma	9.02e-06	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—malignant glioma	9.01e-06	4.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—malignant glioma	8.55e-06	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—malignant glioma	8.4e-06	4.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—malignant glioma	8.32e-06	4.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CB—malignant glioma	8.28e-06	4.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—malignant glioma	8.21e-06	4.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—malignant glioma	7.76e-06	4.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—malignant glioma	7.65e-06	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—malignant glioma	7.16e-06	3.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—malignant glioma	7.13e-06	3.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—malignant glioma	7.1e-06	3.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—malignant glioma	6.95e-06	3.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—malignant glioma	6.9e-06	3.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—malignant glioma	6.56e-06	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—malignant glioma	6.36e-06	3.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—malignant glioma	6.03e-06	3.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—malignant glioma	5.82e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—malignant glioma	5.2e-06	2.76e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—malignant glioma	5.05e-06	2.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—malignant glioma	4.93e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—malignant glioma	4.13e-06	2.19e-05	CbGpPWpGaD
